Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes
Public ClinicalTrials.gov record NCT04982575. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Co-administration of Cagrilintide s.c. 2.4 mg and Semaglutide s.c. 2.4 mg Once Weekly in Subjects With Type 2 Diabetes
Study identification
- NCT ID
- NCT04982575
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Enrollment
- 92 participants
Conditions and interventions
Conditions
Interventions
- Cagrilintide 2.4 mg Drug
- Placebo (cagrilintide) Drug
- Placebo (semaglutide) Drug
- Semaglutide 2.4 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 1, 2021
- Primary completion
- Jul 6, 2022
- Completion
- Jul 6, 2022
- Last update posted
- Dec 22, 2025
2021 – 2022
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Uni of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| Valley Research | Fresno | California | 93720 | — |
| Pacific Clinical Studies | Los Alamitos | California | 90720 | — |
| Velocity Clin Res Los Angeles | Los Angeles | California | 90017 | — |
| Encompass Clinical Research_Spring Valley | Spring Valley | California | 91978 | — |
| New West Physicians,Inc. | Golden | Colorado | 80401 | — |
| FPA Clinical Research | Kissimmee | Florida | 34741 | — |
| Florida Inst For Clin Res | Orlando | Florida | 32825 | — |
| Clinical Trial Res Assoc,Inc | Plantation | Florida | 33324 | — |
| Ellipsis Group | Alpharetta | Georgia | 30022 | — |
| East West Med Res Inst | Honolulu | Hawaii | 96814 | — |
| Macoupin Research Group | Gillespie | Illinois | 62033 | — |
| MD Medical Research | Oxon Hill | Maryland | 20745 | — |
| PharmQuest Life Sciences LLC | Greensboro | North Carolina | 27408 | — |
| Accellacare | Wilmington | North Carolina | 28401 | — |
| Lillestol Research LLC | Fargo | North Dakota | 58104 | — |
| Plains Clinical Research Center, LLC_Fargo | Fargo | North Dakota | 58104 | — |
| Holston Medical Group | Kingsport | Tennessee | 37660 | — |
| Velocity Clinical Res-Dallas | Dallas | Texas | 75230 | — |
| PlanIt Research, PLLC | Houston | Texas | 77079 | — |
| DCOL Ctr for Clin Res | Longview | Texas | 75605 | — |
| Selma Medical Associates | Winchester | Virginia | 22601-3834 | — |
| Capital Clin Res Ctr,LLC | Olympia | Washington | 98502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04982575, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2025 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04982575 live on ClinicalTrials.gov.